FDA Extends Relizorb’s Approval to Children with Cystic Fibrosis Who Are Fed with a Tube
cystic fibrosis, News Relizorb, an enzyme-containing cartridge that breaks down fats in tube-feeding formulas, is now available to children, according to its developer, Alcresta Therapeutics. The U.S. Food and Drug Administration, which approved the device’s use ... Read more